Fetal Growth Restriction: Understanding Interrupted Fetal Development

Fetal Growth Restriction (FGR), formerly IUGR, is failure to reach genetically determined growth potential. It affects 5–10% of pregnancies and is a major contributor to perinatal morbidity/mortality.

Classification

  • Symmetric (20–30%): Global reduction (head + body); early onset (<28 wks); often genetic, congenital infection, severe early placental insufficiency.
  • Asymmetric (70–80%): Sparing of head circumference; abdominal circumference lagging; late onset (>28 wks); uteroplacental insufficiency.

Etiologies

MaternalPlacental/UtetalFetal
Hypertension (chronic, preeclampsia)Placental insufficiency, infarctionChromosomal (Trisomy 13, 18, 21, Turner)
Diabetes (vascular disease)Abnormal implantation (shallow trophoblast)Congenital anomalies, syndromes
Autoimmune (APS, SLE)Placental thrombosis, abruptionCongenital infection (CMV, toxo, rubella, syphilis, Zika, parvovirus)
Renal, cardiac, pulmonary diseaseStructural anomalies (SUA, circumvallate)Multiple gestation (selective IUGR, TTTS)
Malnutrition, substance use (tobacco, cocaine, alcohol)Genetic growth disorders
High altitude

Detection & Monitoring

  • Fundal Height: Lag >3 cm triggers ultrasound.
  • Ultrasound Biometry: AC <10th %ile or <3rd %ile; HC/AC ratio elevated (asymmetric).
  • Doppler Velocimetry: Umbilical artery (UA) PI/S/D → absent/reversed end-diastolic flow (ARED) = severe compromise. Middle cerebral artery (MCA) → brain-sparing (↓PI). Ductus venosus (DV) → pre-terminal.
  • Biophysical Profile (BPP) / NST: Fetal well-being.
  • Growth Trajectory: Serial scans q2–4 wks essential.

Management by Gestation & Severity

  • <34 wks + severe (ARED DV, oligohydramnios, abnormal BPP): Delivery (corticosteroids, MgSO4 neuroprotection).
  • 34–37 wks: Individualize; deliver if deteriorating.
  • >37 wks: Deliver.
  • Mild/Moderate, Preterm: Surveillance, maternal optimization (nutrition, aspirin if indicated, treat maternal disease), timing delivery for best neonatal outcome.

Neonatal & Long-Term Risks

  • Perinatal asphyxia, hypoglycemia, polycythemia, thermoregulation failure, NEC.
  • Long-term: Neurodevelopmental delay, metabolic syndrome (Barker hypothesis), cardiovascular disease, psychiatric disorders.

Multidisciplinary care (MFM, neonatology, genetics, placental pathology) optimizes outcomes.

Baby Health - Related Articles